XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating activities:    
Net (loss) income $ (31,043) $ 4,165
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    
Depreciation and amortization 9,338 3,582
Non-cash rent expense 1,160 1,110
Change in fair value of contingent consideration 12,864  
Gain on sale of software products   (711)
Provision for adjustments to accounts receivable and doubtful accounts 5 (60)
Provision for excess and obsolete inventory (97)  
Gain on disposal of fixed assets (14)  
Non-cash compensation related to stock options and restricted stock 4,848 3,064
Deferred income taxes 58 153
Change in operating accounts:    
Accounts receivable 7,938 (1,269)
Prepaid expenses and other assets (268) (388)
Accounts payable and accrued liabilities (16,309) (1,906)
Deferred revenue (1,396) 184
Net cash (used in) provided by operating activities (12,916) 7,924
Investing activities:    
Acquisitions, net (56,865) (13,500)
Proceeds from sale of software products 192 367
Capital expenditures (830) (1,323)
Purchase of equity instrument   (225)
Net cash used in investing activities (57,503) (14,681)
Financing activities:    
Proceeds from exercise of common stock warrants 2,066 4,196
Payments related to contingent consideration (1,136)  
Proceeds from exercise of stock options 65 29
Proceeds from stock sale for employee stock purchase plan 37 18
Proceeds from common stock offering 59,711  
Net cash provided by financing activities 60,743 4,243
Net decrease in cash and cash equivalents (9,676) (2,514)
Cash and cash equivalents, beginning of year 25,754 28,268
Cash and cash equivalents, end of year 16,078 25,754
Supplemental disclosures of cash flow information:    
Cash paid (received) for income taxes 84 $ (173)
Non-cash investing and financing activities:    
Issuance of common stock in connection with acquisition $ 8,381